April 17 (Bloomberg) -- The sale of AstraZeneca Plc’s Astra Tech, a Swedish unit that makes dental implants and medical devices, has attracted bids from more than 10 companies, the Mail on Sunday reported, without saying where it got the information.
The unit, which is worth 1.3 billion pounds ($2.1 billion) according to the newspaper, received bids from U.K. buyout firm Cinven Ltd., France-based PAI Partners, and U.S.-based Warburg Pincus LLC and Zimmer Holdings Inc., the newspaper said.
AstraZeneca and JPMorgan Chase & Co, which is managing the sale, declined to comment to the newspaper.
To contact the reporter on this story: Agnes Lovasz at email@example.com
To contact the editor responsible for this story: Balazs Penz at firstname.lastname@example.org